Adaptive Biotechnologies went IPO in 2019
Adaptive Biotechnologies is commercial-stage biotech company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease.
Portfolio List
Agralogics
Agralogics provides a data platform for Food and Water Enterprises to improve their operational efficiency through tools to improve in-field collaboration, regulatory compliance, and resource conservation. Using Data Science, Flexible Mobile and Insight and Operational Dashboards, Agralogics provides quantified savings to these Enterprises for their global operations.
Agralogics mission is to enable Food and Water Enterprises to improve their operational efficiency and sustainability using actionable data and information.
Apixio, Inc.
Apixio delivers actionable insights from textual, scanned and coded data for optimal risk assessment, population management and revenue.
Apixio has been acquired by Centene.
Read MoreAquantia
Aquantia, a fabless semiconductor company, raised $61.4M in its initial public offering on Friday November 3, 2017 issuing 6.8 million shares priced at $9/share. The stock closed up nearly 6% at $9.51. Aquantia makes high-speed integrated circuits that help transfer massive amounts of information inside data centers.
Read more about it here and here.
Read MoreAtheer Labs
Atheer is a revolutionary wearable technology company that is creating an immersive mobile 3D platform that allows users to interact with their technology in ways previously not possible.
Read MoreAurora Algae
Aurora Algae was acquired by Reliance Holding USA in 2016.
Read MoreAvantome
BaseHealth
BaseHealth was acquired by Genalyte in March 2020.
BaseHealth makes an integrated health management platform called Genophen. The company leverages the broad appeal of genomics to engage patients with their physicians in a highly-collaborative way.
Read MoreBina Technologies
Bright Context
Cellanome
Cellanome is developing a unique multiomics platform to measure biology at an unprecedented resolution and scale. Central to this vision is our proprietary technology, as well as cutting edge synthetic biology and informatics methods.
Read MoreClear Labs
Clear Labs is the standard for molecular food quality in the global food industry. We are pioneering food analytics to so that the world’s most respected brands can differentiate on quality and stand behind their value.
Read MoreClever Sense
Clever Sense was acquired by Google, Inc (GOOG) in 2011.
Clever Sense developed a context-aware personalization platform that helps people find things around them that match their tastes, using our machine learning & data mining technologies.
Color Genomics, Inc.
Color provides high-quality, physician-ordered, genetic testing at a low cost. We include support for physicians, as well as genetic counseling as part of every purchase. Our goal is to expand physician-supported access to genetic testing to help every person, everywhere understand their risk for hereditary disorders.
Read MoreCOMPLIANCE.AI
Archer, an enterprise leader in providing a fully integrated risk management solution, acquired Compliance.ai, a leading provider of artificial intelligence (AI)-driven regulatory change management solutions in February 2024.
Compliance.ai’s mission is to transform the way highly regulated organizations address compliance risk and to modernize compliance processes for both regulators and regulated entities.
Compliance.ai delivers regulatory change management (RCM) solutions designed specifically for firms in the banking, financial services, and insurance industry (BFSI). Our unique Expert-In-The-Loop methodology ensures expert oversight of advanced machine learning technologies simplify and streamline complex RCM and compliance activities for our clients.
Read MoreDeepSight Technology
DeepSight Technology founded in 2019 by Nader Sadrzadeh, Lan Yang, and Anand Chandrasekher with the vision to revolutionize medical imaging using a proprietary sensing technology. With offices in San Francisco Bay Area and Clayton, Missouri, DeepSight aims to vastly extend the range of diagnostic medical ultrasound to benefit public health and well-being.
Read MoreEncoded Therapeutics
The precision gene therapies being developed at Encoded are capable of potentially targeting specific cell types or levels of expression to address a range of disease mechanisms.
Read Moreinsitro
At insitro, we are building a different kind of drug company to bring better drugs faster to the patients who can benefit most. Through the power of machine learning (ML) and data at scale, we decode the complexities of biology to unlock transformative new medicines.
Read MoreIntegenX
IntegenX was acquired by Thermo Fisher Scientific in March 2018.
IntegenX provides integrated systems enabling microsample preparation and analysis for the life sciences.
Read MoreLitescape
LiteScape Technologies provides their customers with innovative Unified Telecommunications solutions.
Read More